摘要
目的研究拓扑替康(topotecan,TPT)对人肝癌BEL-7402细胞体外迁移、黏附的影响。方法体外培养人肝癌BEL-7402细胞,分为实验组和空白组,实验组分为三个亚组,分别用0.1、0.2、0.3 mmol/L的TPT进行干预,空白组给予不含TPT的培养液。采用划痕实验和Transwell小室迁移实验检测TPT对BEL-7402细胞体外迁移能力的影响,采用黏附实验检测TPT对BEL-7402细胞黏附和异质黏附能力的影响。结果0.2、0.3 mmol/L TPT组中BEL-7402细胞的体外迁移能力受到抑制,同质黏附能力增强,而异质黏附能力减弱,差异具有统计学意义(P均<0.05)。结论拓扑替康可抑制肝癌BEL-7402细胞的迁移和异质黏附能力,增强肝癌细胞的同质黏附能力。
Objective To study the effects of topotecan (TPT) on migration and adhesion of the human hepatoma cell line BEL-7402 cells in vitro. Methods The human hepatoma cell line BEL-7402 cells were cultured in vitro, and divided into two groups: experimental group and control group. The experimental group was divided into three subgroups and treated with 0.1, 0.2 and 0.3 mmol/L TPT respectively. The control group was treated with culture medium without TPT. Effects of TPT on ability of migration of BEL-7402 cells was detected by wound-healing assay and Transwell chamber model. Effects of TPT on ability of homogeneous and heteroge- neous adhesion of BEL-7402 cells was assessed by adhesion experiments. Results The ability of migration and heterogeneous adhesion were significantly depressed in 0.2 and 0.3 mmol/L TPT group (P〈0.05). The ability of homogeneous adhesion was effectively enchanced after treated with 0.2 and 0.3 mmol/L TPT (P〈0.05). Conclusion TPT can depress the migratory and heterogeneous adhesion potentials, and it can enchance the homogeneous adhesion potential of the human hepatoma cell line BEL-7402 cells in vitro.
出处
《肝胆胰外科杂志》
CAS
2014年第1期51-54,共4页
Journal of Hepatopancreatobiliary Surgery
关键词
拓扑替康
肝癌
迁移
黏附
topotecan
hepatic carcinoma
migration
adhesion